Characterization of Statin Dose Response in Electronic Medical Records
- 4 October 2013
- journal article
- research article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 95 (3) , 331-338
Abstract
Efforts to define the genetic architecture underlying variable statin response have met with limited success, possibly because previous studies were limited to effect based on a single dose. We lever...Keywords
This publication has 42 references indexed in Scilit:
- The Electronic Medical Records and Genomics (eMERGE) Network: past, present, and futureGenetics in Medicine, 2013
- Operational Implementation of Prospective Genotyping for Personalized Medicine: The Design of the Vanderbilt PREDICT ProjectClinical Pharmacology & Therapeutics, 2012
- Next generation genome-wide association tool: Design and coverage of a high-throughput European-optimized SNP arrayGenomics, 2011
- Genetics and Variable Drug ResponseJAMA, 2011
- The Emerging Role of Electronic Medical Records in PharmacogenomicsClinical Pharmacology & Therapeutics, 2011
- Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trialsThe Lancet, 2010
- From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locusNature, 2010
- Robust Replication of Genotype-Phenotype Associations across Multiple Diseases in an Electronic Medical RecordThe American Journal of Human Genetics, 2010
- The SLCO1B1*5Genetic Variant Is Associated With Statin-Induced Side EffectsJACC, 2009
- Community consultation and communication for a population‐based DNA biobank: The Marshfield clinic personalized medicine research projectAmerican Journal of Medical Genetics Part A, 2008